Company intelligence / Profile preview

Ningbo Shuangcheng Pharmaceutical

Ningbo, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Ningbo Shuangcheng Pharmaceutical is a specialized pharmaceutical company and a subsidiary of Hainan Shuangcheng Pharmaceutical. The company focuses on the research, development, and large-scale production of peptide-based drugs and chemical synthesis medications. Its facility in Ningbo is designed to meet international GMP standards, including US FDA and EU EMA requirements, positioning it as a key manufacturing hub for the parent group's global expansion. The company provides contract manufacturing (CMO) and development services alongside its own product portfolio, which includes treatments for viral hepatitis and endocrine disorders.

Therapeutic areas: Infectious DiseasesOncologyEndocrinologyGastroenterology
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on Ningbo Shuangcheng Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ningbo Shuangcheng Pharmaceutical.

Explore the full profile